Trademark Overview
On Monday, March 16, 2026, a trademark application was filed for LIDIA-SEQ with the United States Patent and Trademark Office. The USPTO has given the LIDIA-SEQ trademark a serial number of 79448554. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, April 23, 2026. This trademark is owned by DNAE Group Holdings Limited. The LIDIA-SEQ trademark is filed in the Computer & Software Products & Electrical & Scientific Products, Medical Instrument Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Scientific apparatus and instruments; scientific research and laboratory apparatus; apparatus for conducting PCR analysis; apparatus for DNA and RNA amplification and sequencing for research purposes; apparatus for semiconductor sequencing; apparatus for on-chip DNA and RNA amplification sequencing and measurement; silicon transistors; microchips; data processing equipment; computer software; bioinformatics software; software for microbial pathogen detection and identification; computer software for the diagnosis of sepsis, infectious diseases and associated antimicrobial resistance, cancer and other medical conditions; software for genetic sequence analysis for screening and detecting diseases and reporting of test results for healthcare professionals and patients; semiconductors and microchips for sequencing and measurement of DNA and RNA for scientific medical research and veterinary purposes; all for scientific research purposes.
Medical and veterinary apparatus and instruments; apparatus for providing diagnostic sequencing of blood samples, DNA and RNA; apparatus for microbial pathogen detection and identification; apparatus for the diagnosis and monitoring of sepsis and infectious diseases and associated antimicrobial resistance, cancer and other medical conditions; apparatus for DNA and RNA testing for medical purposes; apparatus for the diagnosis and monitoring of cancer; apparatus for testing blood samples, cancer cells, DNA, RNA and protein; apparatus for PCR analysis and DNA and RNA sequencing for medical and veterinary purposes; medical diagnostic apparatus for taking and storing blood samples; vials and other containers in the nature of tubes for blood and other medical sample collection; single use cartridges for use in medical apparatus for analysing biological samples; medical diagnostic test kits for the detecting, analysis and monitoring of medical conditions; medical diagnostic apparatus for test...
Medical and veterinary services; healthcare services; DNA and RNA screening for medical purposes; genetic and blood testing, sequencing and measuring services; medical laboratory services for the analysis of samples taken from patients; provision of information relating to the analysis of DNA and RNA; genetic testing for medical purposes; genome sequencing and analysis services for medical and veterinary diagnostic and treatment purposes; medical diagnostic testing, monitoring and reporting services; consultancy and advisory services relating to the aforesaid services.
Scientific and technological services; laboratory services in the testing, sequencing and measurement of DNA and RNA; medical laboratory services; laboratory analysis; data storage services; software as a service (SaaS) services featuring software for genetic sequence analysis for screening and detecting diseases and reporting of test results for healthcare professionals and patients; consultancy and advisory services relating to the aforesaid services.
